A sustained-release formulation of L-dopa (Madopar HBS) in the treatment of nocturnal and early-morning disabilities in Parkinson's disease.

Source:http://linkedlifedata.com/resource/pubmed/id/3428306

Download in:

View as

General Info

PMID
3428306